Category: Uncategorized

A cohort of premier venture capital firms has invested $130 million into Slate Medicines, a newly established startup based in... Read more

Novo Nordisk has announced a strategic move to broaden patient access in the U.S. market. Starting January 1, 2027, the... Read more

Just one month after the approval of Zycubo for Menkes disease, Fortress Biotech has announced an agreement to sell its... Read more

Pharmaceutical giant Merck & Co. (MSD) has announced a major management reorganization by splitting its core pharmaceutical business into two... Read more

The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Immedica Pharma's Loargys (pegzilarginase) for the treatment... Read more

Seeking to bolster its presence in the Chinese market, Pfizer has entered into a strategic agreement worth up to $495... Read more

AstraZeneca's board has disclosed that CEO Pascal Soriot's realized compensation for 2025 reached 17.7 million pounds ($23.9 million). This represents... Read more

BioMarin Pharmaceutical has announced the withdrawal of Roctavian, the first one-time gene therapy for hemophilia A, after failing to secure... Read more

Pharmaceutical giant Novo Nordisk has announced plans to significantly slash the wholesale acquisition cost (WAC) in the United States for... Read more